Owing to its inter- and intra-tumor heterogeneity inducing capacity, AID/APOBEC family has the potential to affect the pathogenesis and clinical presentation, e.g. prognosis and response to treatment, of lymphomas as well as other malignancies. Here, AICDA is linked to lymphoma.